Cat. #162322
Glioblastoma WHO IV spheroid cell line, NCH481
Cat. #: 162322
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Rehbein et al. 2023. Cancers. 15(21):5249, PMID: 37958423.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV spheroid cell line, NCH481
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV spheroid cell line, NCH481
- Biosafety level: 2
Handling
- Growth medium: DMEM-F12 medium supplemented with glutamine, 20 ng/mL EGF, 20 ng/mL FGF, 20% BIT supplement and penicillin/streptomycin
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Rehbein et al. 2023. Cancers. 15(21):5249. PMID: 37958423.
- Gobin et al. 2019. Cancer Research. 79(6):1226-1238. PMID: 30674534.
- Campos et al. 2014. J Pathol. 234(1):23-33. PMID: 24756862.
